Cargando…
Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
Drug discovery is usually a rule-based process that is carefully carried out by pharmacists. However, a new trend is emerging in research and practice where artificial intelligence is being used for drug discovery to increase efficiency or to develop new drugs for previously untreatable diseases. Ne...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785219/ https://www.ncbi.nlm.nih.gov/pubmed/36558943 http://dx.doi.org/10.3390/ph15121492 |
_version_ | 1784857995801264128 |
---|---|
author | Karger, Erik Kureljusic, Marko |
author_facet | Karger, Erik Kureljusic, Marko |
author_sort | Karger, Erik |
collection | PubMed |
description | Drug discovery is usually a rule-based process that is carefully carried out by pharmacists. However, a new trend is emerging in research and practice where artificial intelligence is being used for drug discovery to increase efficiency or to develop new drugs for previously untreatable diseases. Nevertheless, so far, no study takes a holistic view of AI-based drug discovery research. Given the importance and potential of AI for drug discovery, this lack of research is surprising. This study aimed to close this research gap by conducting a bibliometric analysis to identify all relevant studies and to analyze interrelationships among algorithms, institutions, countries, and funding sponsors. For this purpose, a sample of 3884 articles was examined bibliometrically, including studies from 1991 to 2022. We utilized various qualitative and quantitative methods, such as performance analysis, science mapping, and thematic analysis. Based on these findings, we furthermore developed a research agenda that aims to serve as a foundation for future researchers. |
format | Online Article Text |
id | pubmed-9785219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97852192022-12-24 Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda Karger, Erik Kureljusic, Marko Pharmaceuticals (Basel) Article Drug discovery is usually a rule-based process that is carefully carried out by pharmacists. However, a new trend is emerging in research and practice where artificial intelligence is being used for drug discovery to increase efficiency or to develop new drugs for previously untreatable diseases. Nevertheless, so far, no study takes a holistic view of AI-based drug discovery research. Given the importance and potential of AI for drug discovery, this lack of research is surprising. This study aimed to close this research gap by conducting a bibliometric analysis to identify all relevant studies and to analyze interrelationships among algorithms, institutions, countries, and funding sponsors. For this purpose, a sample of 3884 articles was examined bibliometrically, including studies from 1991 to 2022. We utilized various qualitative and quantitative methods, such as performance analysis, science mapping, and thematic analysis. Based on these findings, we furthermore developed a research agenda that aims to serve as a foundation for future researchers. MDPI 2022-11-30 /pmc/articles/PMC9785219/ /pubmed/36558943 http://dx.doi.org/10.3390/ph15121492 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Karger, Erik Kureljusic, Marko Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda |
title | Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda |
title_full | Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda |
title_fullStr | Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda |
title_full_unstemmed | Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda |
title_short | Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda |
title_sort | using artificial intelligence for drug discovery: a bibliometric study and future research agenda |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785219/ https://www.ncbi.nlm.nih.gov/pubmed/36558943 http://dx.doi.org/10.3390/ph15121492 |
work_keys_str_mv | AT kargererik usingartificialintelligencefordrugdiscoveryabibliometricstudyandfutureresearchagenda AT kureljusicmarko usingartificialintelligencefordrugdiscoveryabibliometricstudyandfutureresearchagenda |